Steve Klass | VP, Burns McClellan |
Dr. Thomas Schall | President and CEO |
Susan Kanaya | EVP and Chief Financial and Administrative Officer |
Bill Fairey | COO |
Konstantinos Aprilakis | JMP Securities |
Tessa Romero | JP Morgan |
Steven Seedhouse | Raymond James |
Michelle Gilson | Canaccord |
Good afternoon. And welcome to the ChemoCentryx Second Quarter 2018 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session.
As a reminder, this conference call will be recorded.